Eventide Asset Management – ENTASIS THERAPEUTICS

Eventide Asset Management ownership history of ENTASIS THERAPEUTICS
QuarterValueSharesWeighting
Q1 2021$1,264
-38.8%
590,602
-32.9%
0.02%
-40.6%
Q4 2020$2,064
21.1%
879,5410.0%0.03%
-3.0%
Q3 2020$1,705
-31.1%
879,5410.0%0.03%
-38.9%
Q2 2020$2,473
16.0%
879,5410.0%0.05%
-21.7%
Q1 2020$2,131
-50.4%
879,5410.0%0.07%
-43.0%
Q4 2019$4,300
87.9%
879,541
124.1%
0.12%
59.2%
Q3 2019$2,288
-58.5%
392,513
-55.4%
0.08%
-54.8%
Q2 2019$5,516
-4.5%
879,5410.0%0.17%
-15.6%
Q1 2019$5,776
65.9%
879,5410.0%0.20%
29.2%
Q4 2018$3,481
-57.2%
879,541
13.8%
0.15%
-48.5%
Q3 2018$8,140772,5560.30%